Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interferon-gamma With Interferon Alpha and Ribavirin for Hepatitis C Patients Who Are Non-responders to Interferon Alpha Plus Ribavirin

NCT00538811 is registered in ClinicalTrials.gov with Aga Khan University as lead sponsor.

NCT NCT00538811
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00538811 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interferon-gamma With Interferon Alpha and Ribavirin for Hepatitis C Patients Who Are Non-responders to Interferon Alpha Plus Ribavirin
Lead sponsor
Aga Khan University
Phase
Phase 2/3
Overall status
Completed
Start date
Not reported
Completion date
Not reported
Enrollment
40 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

genotype 3, hepatitis c, non-responders, relapsers